The British Pharmacopoeia Commission has caused this British Pharmacopoeia 2022 to be prepared under regulation 317(1) of the Human Medicines Regulations 2012 and, in accordance with regulation 317(4), the Ministers have arranged for it to be published.
The British Pharmacopoeia 2022 contributes significantly to the quality control of medicinal products for human use. It contains publicly available, legally enforceable standards that provide an authoritative statement of the quality that a product, material or article is expected to meet at any time during its period of use. The pharmacopoeial standards are designed to complement and assist the licensing and inspection processes and are part of the overall system for safeguarding the health of purchasers and users of medicinal products in the UK.
The British Pharmacopoeia also has an important role to play internationally, being used across the globe and referenced in the national legislation of several countries.
British Pharmacopoeia 2022
The British Pharmacopoeia 2022 supersedes the British Pharmacopoeia 2021. It has been prepared by the British Pharmacopoeia Commission, with the collaboration and support of its Expert Advisory Groups, Panels of Experts and Working Parties and contains approximately 4000 monographs for substances, preparations and articles used in the practice of medicine. Some of these monographs are of national origin and have been elaborated or revised under the auspices of the British Pharmacopoeia Commission whilst others (indicated to users by a chaplet of stars) have been elaborated, or revised, under the auspices of the European Pharmacopoeia Commission, supported by its Groups of Experts and Working Parties, and are reproduced from the European Pharmacopoeia. This edition, together with its companion volume, the British Pharmacopoeia (Veterinary) 2022, incorporates all the monographs of the lOth Edition of the European Pharmacopoeia, as amended by Supplements 10.1 and 10.5. Users of the British Pharmacopoeia thereby benefit by finding within this comprehensively indexed compendium all current United Kingdom pharmacopoeial standards for medicines for human use.
|
Volume |
Content
|
|
Volumes I and II |
Medicinal Substances |
|
Volume III |
Formulated Preparations: General Monographs Formulated Preparations:
Specific Monographs |
|
Volume IV |
Herbal Drugs, Herbal Drug Preparations and Herbal
Medicinal Products Materials for use in the Manufacture of Homoeopathic
Preparations Blood-related Products Immunological Products
Radiopharmaceutical Preparations Surgical Materials |
|
Volume V |
Infrared Reference Spectra Appendices Supplementary Chapters Index |
|
Volume VI |
British Pharmacopoeia (Veterinary) 2022 |
Effective Date
The effective date for British Pharmacopoeia monographs in this edition is 1 January 2022.
National monographs omitted from this or earlier editions of the British Pharmacopoeia remain effective in accordance with Regulation 252(2)(c) of the Human Medicines Regulations 2012, as amended.
.JPG)
0 Comments